Skip to content
BALCAO · SERVICES-MEDICAL LABORATORIES

First Choice Healthcare Solutions, Inc. FCHS

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$-7.0M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Although we still provide rehabilitative services on a limited basis, such as physical therapy, as part of our go-forward strategy, we will terminate all of our remaining legacy orthopedic and physical therapy services and focus the company resources on our strategy of building and operating medical functional health and wellness clinics. The first wholly owned subsidiary, FCID Medical, Inc. (“FCID Medical”) is the subsidiary under which we own and operate First Choice Medical Group of Brevard, LLC, (“FCMG”), our original medical services practice. The second wholly owned subsidiary, The Good Clinic Properties, LLC is the subsidiary under which we have leased clinic facilities. Our go forward strategy will be executed using a corporate structure of centralized management services designated as Leading Primary Care, Inc. with three operating subsidiaries, Live Well Medical Group (comprised of the primary care clinic locations nationally), The Good Clinic Properties, Inc. (which holds leases on all physical clinic locations), and Live Well Drugstore, Inc. (comprised of our current and future compounding pharmacy operations). Historically, we offered fully integrated Orthopedic services, delivering diagnostics, surgery and treatment services.

Written from the business description in First Choice Healthcare Solutions, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 11 March 2026. Every sentence was checked against that document before publication.

Growth

·
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2013 · Revenue 1.0 · Net income -4.7
0.5M1.0M-2.5M-5.0M
20102013201620232025
Compound annual growth
−6.0%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2013 · Operating -93.3% · Net -448.7%
-200%-400%
201020152025
ROE
FY2017 · ROE 31.2%
50%100%
201020152025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2023 · FCF -6.9
-2.5M-5.0M
201020152025

Total assetsUSD 4.0M
EquityUSD -39.5M
CashUSD 5,896.00
Current ratio0.00×

Equity funds -977% of total assets.

The 12-year record

12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
FCHS, 12-year financial record
Metric 202520242023202220172016201520142013201220112010
Revenue $B◌◌◌◌◌◌◌◌0.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.00.0
EBITDA $B−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.00.0−0.0◌
Income tax $B◌0.0◌◌◌◌0.00.00.0−0.0−0.00.0
Net income $B−0.0−0.0−0.0−0.00.00.0−0.0−0.0−0.0−0.0−0.00.0
Free cash flow $B◌◌−0.0−0.0−0.0−0.00.0−0.0−0.0−0.00.0◌
EPS, diluted $−0.21−0.12−0.25−0.300.150.37−0.17−0.14−0.35−0.07−0.530.00
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————
ROE %————31.2114.2——————
Shares out B0.030.030.030.030.030.020.020.020.020.010.050.05

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 12 of the 12 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Medical Laboratories
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2010

Share this section

Download image